Clinical Evaluation of the Computerized Chronic Urticaria-specific Quality of Life Questionnaire in Korean Patients with Chronic Urticaria
Overview
Affiliations
Background: Chronic urticaria (CU) is a common skin disorder that affects the well-being and quality of life (QOL) of patients. Recently, we developed and validated a questionnaire for measuring QOL in Korean patients with CU, called the Chronic Urticaria-Specific Quality of Life (CU-QOL) questionnaire.
Aim: To evaluate the clinical significance of a computerized version of the CU-QOL, in adult patients with CU.
Methods: This was a cross-sectional observational study that enrolled 249 Korean patients with CU from five university hospitals and measured computerized CU-QOL scores and Urticaria Activity Score (UAS) simultaneously. The internal consistency of the computerized CU-QOL was analysed using Cronbach α. To identify clinical correlations between the CU-QOL and patient characteristics, the atopic status and serum autoantibodies, including antinuclear, antithyroglobulin and antimicrosome antibodies, were measured. Multiple linear regression models were used to identify CU-QOL predictors.
Results: Cronbach α was 0.94 for the overall computerized CU-QOL score. The CU-QOL scores correlated significantly with the UAS (r= -0.49, P<0.001). Of the factors aggravating CU, delayed pressure, sunlight exposure and emotional stress significantly influenced the overall CU-QOL scores in the univariate analysis. Multivariate regression models indicated that UAS and emotional stress were significant predictors of the four domains and of the total CU-QOL scores.
Conclusions: The computerized CU-QOL is a convenient and valid tool for measuring QOL in patients with CU. This study suggests that UAS, dermatographism and emotional stress are strong CU-QOL predictors in Korean patients with CU.
Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines.
Kim M, Choi J, Shin Y, Park H, Ye Y Allergy Asthma Immunol Res. 2023; 15(4):496-511.
PMID: 37153977 PMC: 10359646. DOI: 10.4168/aair.2023.15.4.496.
The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.
Ye Y, Koh Y, Choi J, Kim M, Park J, Kim T Korean J Intern Med. 2022; 37(5):1050-1060.
PMID: 36068718 PMC: 9449199. DOI: 10.3904/kjim.2022.078.
Badura-Brzoza K, Brzoza Z J Clin Med. 2021; 10(13).
PMID: 34203132 PMC: 8268328. DOI: 10.3390/jcm10132852.
Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria.
Choi J Allergy Asthma Immunol Res. 2021; 13(3):357-359.
PMID: 33733631 PMC: 7984949. DOI: 10.4168/aair.2021.13.3.357.
Choi J, Lee D, Song W, Choi M, Kwon J, Kim G Allergy Asthma Immunol Res. 2020; 12(5):750-770.
PMID: 32638557 PMC: 7346997. DOI: 10.4168/aair.2020.12.5.750.